Fructooligosaccharides (FOS) के लिए Irritable Bowel Syndrome (IBS)

Q: Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

Q: How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Key Study Findings

Other

FODMAP Profile of Wholegrain Pasta.

Dose: None बनाम: None Outcome: FODMAP compound content in pasta (analytical) प्रभाव: None None

जनसंख्या: Commercially available pasta products (analytical study)

Randomized Controlled Trial n=9 12 weeks

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: …

Dose: None बनाम: Baseline; crossover between 3 diets Outcome: Birmingham IBS questionnaire symptom score प्रभाव: 75% relief on low FOS+GOS; 62.5% on FODMAP p<0.05

जनसंख्या: IBS patients (Rome IV criteria)

Other

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.

Dose: None बनाम: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers प्रभाव: Up to 99.5% FODMAP reduction (wheat malt) None

जनसंख्या: Laboratory food science study (no human subjects)

Randomized Controlled Trial 12 weeks Double-blind

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides …

Dose: None बनाम: Placebo Outcome: Quality of life प्रभाव: None p = 0.023

जनसंख्या: IBS patients

In Vitro

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Controlled Clinical Trial n=54 3.0 weeks

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …

Dose: 350 mg बनाम: None Outcome: IBS symptom improvement प्रभाव: None None

जनसंख्या: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Key Statistics

अध्ययन

150

प्रतिभागी

↔

Mixed

ग्रेड

Referenced Papers

FODMAP Profile of Wholegrain Pasta. Other

Foods (Basel, Switzerland) 2025 3 उद्धरण

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers. Other

Foods (Basel, Switzerland) 2025 1 उद्धरण

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study. Other

Gastroenterology research and … 2025

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … Other

Journal of clinical … 2024 4 उद्धरण

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Other

Frontiers in nutrition 2023 8 उद्धरण

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … Other

Voprosy pitaniia 2023

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 उद्धरण

Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts. Other

FASEB journal : … 2022 16 उद्धरण

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of … Other

Journal of clinical … 2022 12 उद्धरण

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal … RCT

Nutrients 2022 8 उद्धरण

Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Other

Expert review of … 2022 8 उद्धरण

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Other

Food chemistry: X 2021 64 उद्धरण

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation. Other

Foods (Basel, Switzerland) 2021 10 उद्धरण

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … RCT

Nutrients 2020 78 उद्धरण

Impact of Cultivation Method and Cultivar Selection on Soluble Carbohydrates and Pungent Principles in Onions ( Allium cepa L.). Other

Journal of agricultural … 2018 13 उद्धरण

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 उद्धरण

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. RCT

Nutrition journal 2017 10 उद्धरण

[Contemporary dietotherapy of the irritable bowel syndrome]. Review

Voprosy pitaniia 2013

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. RCT

The American journal … 2000 136 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

अधिकतम सीमा: Well-tolerated up to 20 g/day; start low to avoid excess gas

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
None	--	Neutral	--
None	12 weeks	Positive	9
None	--	Positive	--
None	12 weeks	Positive	--
None	--	Mixed	--
350 mg	3.0 weeks	Positive	54
None	--	Mixed	--
None	--	Negative	--

सेवन का सर्वोत्तम समय: With meals; divide doses throughout the day

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

ज्ञात अंतःक्रियाएँ

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

सहनीय अधिकतम सेवन: Well-tolerated up to 20 g/day; start low to avoid excess gas

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Related Evidence

इसके लिए अन्य सामग्री Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

Fructooligosaccharides (FOS) अन्य स्वास्थ्य स्थितियों के लिए

Chronic Constipation C

संक्षिप्त निष्कर्ष

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Evidence Strength30%

Low confidence

अध्ययन विश्लेषण

RCT (5)Meta (0)Other (0)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Irritable Bowel Syndrome (IBS)

अधिक जानें

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।